Cutera (CUTR) Q2 2012 Earnings Call August 06, 2012 5:00 pm ET Executives John Mills - Senior Managing Director Kevin P. Connors - Chief Executive Officer, President and Director Ronald J. Santilli - Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Finance & Administration Analysts Dalton L. Chandler - Needham & Company, LLC, Research Division Morris Ajzenman - Griffin Securities, Inc., Research Division Michael A. Dinerman - Piper Jaffray Companies, Research Division Anthony V. Vendetti - Maxim Group LLC, Research Division Larry Haimovitch - Haimovitch Medical Technology Consultants David Levy PresentationOperator
Greetings, and welcome to the Cutera, Inc. Second Quarter 2012 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, John Mills of ICR. Thank you, Mr. Mills. You may begin. John Mills Thank you. By now, everyone should have access to the second quarter 2012 earnings release, which went out at approximately 4:00 p.m. Eastern time today. The release is available on the Investor Relations portion of Cutera's website at cutera.com, and with its Form 8-K filed today with the SEC and available its website at sec.gov. Before we begin, Cutera would like to remind everyone that these prepared remarks contain forward-looking statements, including statements concerning domestic and international growth opportunities and strategies; future spending; expense management and execution on various aspects of Cutera's operations and business; expectations for increasing revenue, generating cash, improving gross margins and profitability; the development and commercialization of existing and planned new products; potential revenue growth from strategic alliances and planned new products; and financial performance and integration risk associated with the Iridex aesthetic business unit acquisition.